Farringdon Capital, Ltd. Becton Dickinson & CO Transaction History
Farringdon Capital, Ltd.
- $242 Billion
- Q4 2024
A detailed history of Farringdon Capital, Ltd. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 3,919 shares of BDX stock, worth $880,991. This represents 0.37% of its overall portfolio holdings.
Number of Shares
3,919Holding current value
$880,991% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding BDX
# of Institutions
1,796Shares Held
258MCall Options Held
1.23MPut Options Held
866K-
Vanguard Group Inc Valley Forge, PA26.7MShares$6.01 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$3.17 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.78 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.73 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $64.1B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...